VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients

Journal of Heart and Lung Transplantation

Volumn 32, Issue 1, 2013, Pages 120-128

  Daly, Kevin P ^a,b   Seifert, Michael E ^a,b   Chandraker, Anil ^b,c   Zurakowski, David ^a,b   Nohria, Anju ^b,c   Givertz, Michael M ^b,c   Karumanchi, S Ananth ^b,d   Briscoe, David M ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

angiogenic proteins; biologic markers; coronary artery disease; heart transplantation

Indexed keywords

AMPHIREGULIN; ANGIOGENIC FACTOR; ANGIOPOIETIN 2; ARTEMIN; AZATHIOPRINE; BIOLOGICAL MARKER; CYCLOSPORIN; ENDOTHELIN 1; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERSEPHIN; PREDNISONE; RAPAMYCIN; SERINE PROTEINASE INHIBITOR; SERPIN F1; SERPINB5; TACROLIMUS; THROMBOCYTE FACTOR 4; THROMBOSPONDIN 1; THROMBOSPONDIN 2; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN A; VASCULOTROPIN C; VASOHIBIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HEART GRAFT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANGIOGENESIS INDUCING AGENTS; BIOLOGICAL MARKERS; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84871377918     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.09.030     Document Type: Article

References (56)

1. R. Kirk, L.B. Edwards, and A.Y. Kucheryavaya The registry of the International Society for Heart and Lung Transplantation: fourteenth pediatric heart transplantation report - 2011 J Heart Lung Transplant 30 2011 1095 1103
2. J. Stehlik, L.B. Edwards, and A.Y. Kucheryavaya The registry of the International Society for Heart and Lung Transplantation: twenty-eighth adult heart transplant report - 2011 J Heart Lung Transplant 30 2011 1078 1094
3. S. Arora, T. Ueland, and B. Wennerblom Effect of everolimus introduction on cardiac allograft vasculopathy - results of a randomized, multicenter trial Transplantation 92 2011 235 243
4. E. Raichlin, J.H. Bae, and Z. Khalpey Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation Circulation 116 2007 2726 2733 (Pubitemid 350291245)
5. D. Schmauss, and M. Weis Cardiac allograft vasculopathy - recent developments Circulation 117 2008 2131 2141 (Pubitemid 351596195)
6. R.J. Zimmer, and M.S. Lee Transplant coronary artery disease JACC Cardiovasc Interv 3 2010 367 377
7. P. Libby, and J.S. Pober Chronic rejection Immunity 14 2001 387 397 (Pubitemid 32441591)
8. D.M. Briscoe, A.C. Yeung, and F.J. Schoen Predictive value of inducible endothelial cell adhesion molecule expression for acute rejection of human cardiac allografts Transplantation 59 1995 204 211
9. D.M. Briscoe, S.I. Alexander, and A.H. Lichtman Interactions between T lymphocytes and endothelial cells in allograft rejection Curr Opin Immunol 10 1998 525 531 (Pubitemid 28479183)
10. J.S. Pober Immunobiology of human vascular endothelium Immunol Res 19 1999 225 232 (Pubitemid 29401379)
11. M.D. Denton, S.F. Davis, and M.A. Baum The role of the graft endothelium in transplant rejection: evidence that endothelial activation may serve as a clinical marker for the development of chronic rejection Pediatr Transplant 4 2000 252 260
12. J.S. Pober Endothelial activation: intracellular signaling pathways Arthritis Res 4 suppl 3 2002 S109 S116
13. I.H. Vos, and D.M. Briscoe Endothelial injury: cause and effect of alloimmune inflammation Transpl Infect Dis 4 2002 152 159 (Pubitemid 35364780)
14. J.S. Pober, and W.C. Sessa Evolving functions of endothelial cells in inflammation Nat Rev Immunol 7 2007 803 815 (Pubitemid 47480307)
15. X. Zhang, and E.F. Reed Effect of antibodies on endothelium Am J Transplant 9 2009 2459 2465
16. S. Bruneau, C. Woda, and K. Daly Key features of the intragraft microenvironment that determine long-term survival following transplantation Front Immunol 2012 3
17. R.S. Al-Lamki, J.R. Bradley, and J.S. Pober Endothelial cells in allograft rejection Transplantation 86 2008 1340 1348
18. P. Libby, and D.X. Zhao Allograft arteriosclerosis and immune-driven angiogenesis Circulation 107 2003 1237 1239 (Pubitemid 36314403)
19. J.S. Pober, C.G. Orosz, and M.L. Rose Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 61 1996 343 349 (Pubitemid 26067901)
20. A. Valujskikh, and P.S. Heeger Emerging roles of endothelial cells in transplant rejection Curr Opin Immunol 15 2003 493 498 (Pubitemid 37130187)
21. D. Kreisel, A.S. Krupnick, and A.E. Gelman Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: an alternative mechanism of allorecognition Nat Med 8 2002 233 239 (Pubitemid 34250100)
22. B. Sis, G.S. Jhangri, and S. Bunnag Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
23. M.E. Billingham Dilemma of variety of histopathologic grading systems for acute cardiac allograft rejection by endomyocardial biopsy J Heart Transplant 9 1990 272 276 (Pubitemid 20343250)
24. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720 (Pubitemid 41641841)
25. M.R. Mehra, M.G. Crespo-Leiro, and A. Dipchand International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy - 2010 J Heart Lung Transplant 29 2010 717 727
26. A.S. Nagji, T. Hranjec, and B.R. Swenson Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation Ann Thorac Surg 90 2010 168 175
27. L.P. Abramson, E. Pahl, and L. Huang Serum vascular endothelial growth factor as a surveillance marker for cellular rejection in pediatric cardiac transplantation Transplantation 73 2002 153 156 (Pubitemid 34094705)
28. J. Bayliss, M. Bailey, and A. Leet Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy Transplantation 86 2008 991 997
29. M.C. Deng, H.J. Eisen, and M.R. Mehra Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling Am J Transplant 6 2006 150 160 (Pubitemid 43382213)
30. M.X. Pham, J.J. Teuteberg, and A.G. Kfoury Gene-expression profiling for rejection surveillance after cardiac transplantation N Engl J Med 362 2010 1890 1900
31. Q.J. Cai, U.C. Rangasetty, and A. Barbagelata Cardiac allograft vasculopathy advances in diagnosis Cardiol Rev 19 2011 30 35
32. B. Barleon, S. Sozzani, and D. Zhou Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336 3343 (Pubitemid 26115364)
33. M.E. Reinders, M. Sho, and A. Izawa Proinflammatory functions of vascular endothelial growth factor in alloimmunity J Clin Invest 112 2003 1655 1665 (Pubitemid 38063723)
34. M.E. Reinders, T.J. Rabelink, and D.M. Briscoe Angiogenesis and endothelial cell repair in renal disease and allograft rejection J Am Soc Nephrol 17 2006 932 942
35. M. Edelbauer, D. Datta, and I.H. Vos Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo Blood 116 2010 1980 1989
36. N. Ferrara VEGF-A: a critical regulator of blood vessel growth Eur Cytokine Netw 20 2009 158 163
37. K.B. Lemstrom, R. Krebs, and A.I. Nykanen Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis Circulation 105 2002 2524 2530 (Pubitemid 34568975)
38. R.J. Torry, C.A. Labarrere, and D.S. Torry Vascular endothelial growth factor expression in transplanted human hearts Transplantation 60 1995 1451 1457 (Pubitemid 26012679)
39. H.L. Pilmore, J.M. Eris, and D.M. Painter Vascular endothelial growth factor expression in human chronic renal allograft rejection Transplantation 67 1999 929 933 (Pubitemid 29169143)
40. M.E. Reinders, J.C. Fang, and W. Wong Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection Transplantation 76 2003 224 230 (Pubitemid 36877141)
41. D.M. Girnita, M.M. Brooks, and S.A. Webber Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study Transplantation 85 2008 1632 1639
42. D.M. Girnita, E.L. Ohmann, and M.M. Brooks Gene polymorphisms impact the risk of rejection with hemodynamic compromise: a multicenter study Transplantation 91 2011 1326 1332
43. M. Shahbazi, A.A. Fryer, and V. Pravica Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 2002 260 264 (Pubitemid 34042036)
44. A.I. Nykanen, H. Sandelin, and R. Krebs Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth actor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts Circulation 121 2010 1413 1422
45. D. Kerjaschki, H.M. Regele, and I. Moosberger Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates J Am Soc Nephrol 15 2004 603 612 (Pubitemid 38294790)
46. A. Dashkevich, C. Heilmann, and G. Kayser Lymph angiogenesis after lung transplantation and relation to acute organ rejection in humans Ann Thorac Surg 90 2010 406 412
47. O. Thaunat, N. Patey, and G. Caligiuri Chronic rejection triggers the development of an aggressive intragraft immune response through recapitulation of lymphoid organogenesis J Immunol 185 2010 717 728
48. N. Yin, N. Zhang, and G. Lal Lymphangiogenesis is required for pancreatic islet inflammation and diabetes PLoS One 6 2011 e28023
49. J. Vandercappellen, J. van Damme, and S. Struyf The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer Cytokine Growth Factor Rev 22 2011 1 18
50. R.R. Koenen, P. von Hundelshausen, and I.V. Nesmelova Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice Nat Med 15 2009 97 103
51. S. Pitsilos, J. Hunt, and E.R. Mohler Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters Thromb Haemost 90 2003 1112 1120 (Pubitemid 38004432)
52. C.A. Labarrere, J.R. Woods, and J.W. Hardin Early prediction of cardiac allograft vasculopathy and heart transplant failure Am J Transplant 11 2011 528 535
53. C.A. Labarrere, J.R. Woods, and J.W. Hardin Value of the first post-transplant biopsy for predicting long-term cardiac allograft vasculopathy (CAV) and graft failure in heart transplant patients PLoS One 7 2012 e36100
54. G.L. Klement, T.T. Yip, and F. Cassiola Platelets actively sequester angiogenesis regulators Blood 113 2009 2835 2842
55. J.A. Jackson, E.J. Kim, and B. Begley Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection Am J Transplant 11 2011 2228 2234
56. J. Strehlau, M. Pavlakis, and M. Lipman Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation Proc Natl Acad Sci USA 94 1997 695 700 (Pubitemid 27053696)